Skip to content

Clinical trials

Major Depressive Disorder trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Country / region: China Clear all

192 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20062
20073
20081
20092
20102
20112
20125
20134
20145
20157
20164
20178
201810
201911
202019
202116
202219
202318
202416
202515
202620

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status76
Completed69
Recruiting28
Not yet recruiting13
Active, not recruiting2
Terminated2
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shanghai Mental Health Center33
Changping Laboratory9
Central South University7
Capital Medical University6
First Affiliated Hospital of Zhejiang University5
Guangzhou Psychiatric Hospital5
Xiaomei Shao5
Eli Lilly and Company4
First Affiliated Hospital of Chongqing Medical University4
Peking University Sixth Hospital4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder192
Bipolar Disorder15
Depressive Disorder, Treatment-Resistant11
Depressive Disorder10
Schizophrenia7
Anxiety Disorders4
Cognitive Dysfunction4
Mental Disorders4
Anhedonia3
Generalized Anxiety Disorder3

Trials

Showing 1 to 25 of 192. Each trial links to its page on Pharma Observatory.

92 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.